Exchange: NASDAQ·Updated 07:59 PM EDT
SPRY logo

SPRY ARS Pharmaceuticals Inc

$5.62
$0.05
(0.88%)
Today
Closed $5.62
$0.02
(0.36%)
After Hours
Reported EarningsAug 13
Mkt Cap$563.87M
Vol852,847.00

About SPRY

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
34

Bearish Sentiment

How do you feel about SPRY?

Advertisement|Remove ads.